Phase 3 Diabetes Type 2 Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 3
The FAME 2 Kidney trial is a study of whether fenofibrate is able to slow kidney disease progression in adults with type 2 diabetes with moderate kidney damage
Diabetes Type 2
Baker Heart & Diabetes Research Insitute1,000 enrolled4 locationsACTRN12625001170415
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084